loader

World Tenders & Procurement Opportunities

546490- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 of the Social Code Book V with the option to join at any time, so-called approval model 2024-07

World Biggest Tenders Source

This tender with title 546490- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 of the Social Code Book V with the option to join at any time, so-called approval model 2024-07 has been published on Bidding Source portal dated 25 Aug 2025 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

546490- Germany – Pharmaceutical products – Open framework agreement on pharmaceutical discounts pursuant to Section 130a Paragraph 8 of the Social Code Book V with the option to join at any time, so-called approval model 2024-07
Invitation for Bids
546490
Germany
25 Aug 2025
5 Jul 2026
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

550903- Germany – Pharmaceutical products – Open house drug discount agreements for the active ingredient Rivaroxaban, only film-coated tablets excl. strength 2.5 mg, ATC B01AF01 Germany 547285- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a, Paragraph 8 of the Social Code Book V (Open House Model) Germany 550855- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the period from 01.10.2025 to 30.09.2027 Germany 549485-Awarded - Germany – Pharmaceutical products – Cancellation of the open-house procedure for drug discount agreements Rivaroxaban, only film-coated tablets excl. 2.5 mg strength, ATC B01AF01 Germany 541953- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V on active ingredients (medicinal products) - VV 86 Germany 540952- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a, Paragraph 8 of the Social Code Book V for the active ingredient Naloxegol -VV 86 Germany 538062- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient allergen extract from house dust mites (excluding Orylmyte), ATC V01AA03 for the period 01.10.2025 - 30.09.2027 Germany 540736- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient allergen extract from house dust mites (excluding Acarizax), ATC V01AA03 for the period 01.10.2025 - 30.09.2027 Germany 539045- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 SGB V for the active ingredient Cariprazine, ATC N05AX15 for the period 01.10.2025 - 30.09.2027 Germany 533448- Germany – Pharmaceutical products – Open house drug discount contracts Dornase alfa (Deoxyribonuclease), ATC R05CB13 Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans